Pharmaceutical and biotech patent law:
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York City
Practising Law Institute
[2022]
|
| Ausgabe: | 2022 edition |
| Schriftenreihe: | Practicing Law Institute Intellectual property law library
|
| Schlagworte: | |
| Beschreibung: | Auf der Titelseite: "#343424" - Beilage: "Highlights of this edition include" |
| Beschreibung: | 1 Band (verschiedene Seitenzählungen) Illustrationen 25 cm Beilage: 1 Blatt |
| ISBN: | 9781402441394 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV048616946 | ||
| 003 | DE-604 | ||
| 005 | 20230224 | ||
| 007 | t | ||
| 008 | 221219s2022 a||| |||| 00||| eng d | ||
| 020 | |a 9781402441394 |9 978-1-4024-4139-4 | ||
| 020 | |z 1402441398 |9 1402441398 | ||
| 035 | |a (DE-599)BVBBV048616946 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M382 | ||
| 245 | 1 | 0 | |a Pharmaceutical and biotech patent law |c Arnold & Porter Kaye Scholer LLP ; edited by David K. Barr and Daniel L. Reisner |
| 250 | |a 2022 edition | ||
| 264 | 1 | |a New York City |b Practising Law Institute |c [2022] | |
| 300 | |a 1 Band (verschiedene Seitenzählungen) |b Illustrationen |c 25 cm |e Beilage: 1 Blatt | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Practicing Law Institute Intellectual property law library | |
| 500 | |a Auf der Titelseite: "#343424" - Beilage: "Highlights of this edition include" | ||
| 505 | 8 | |a Chapter 1. A brief introduction to the United States Patent System -- Chapter 2. An overview of research & development, product launch, and patent enforcement -- Chapter 3. Utility and patentable subject matter requirements -- Chapter 4. Inventorship -- Chapter 5. Patentability -- Chapter 6. Biological deposits -- Chapter 7. Types of biological and pharmaceutical patents -- Chapter 8. The Hatch-Waxman Act -- Chapter 9. Claim construction -- Chapter 10. Patent infringement -- Chapter 11. Experimental use defense to patent infringement -- Chapter 12. Government funded research: Bayh-Dole and other acts -- Chapter 13. Antitrust, FTC, and state competition law -- Chapter 14. Biologic and biosimilar drug products -- Appendix A. Glossary of biotechnology terminology from case law -- Appendix B. Primer on basic biotechnology concepts -- Appendix C. The science of biosimilars | |
| 650 | 4 | |a Biotechnology / United States / Patents | |
| 650 | 4 | |a Biotechnology industries / United States | |
| 650 | 4 | |a Pharmaceutical industry / United States | |
| 650 | 4 | |a Patent licenses / United States | |
| 650 | 4 | |a Research and development partnership / United States | |
| 650 | 4 | |a Patent laws and legislation / United States | |
| 650 | 4 | |a Inventions / United States / Patents | |
| 650 | 4 | |a Patent suits / United States | |
| 650 | 4 | |a Bioethics | |
| 650 | 4 | |a Intellectual property / Valuation / United States | |
| 650 | 7 | |a Bioethics |2 fast | |
| 650 | 7 | |a Biotechnology |2 fast | |
| 650 | 7 | |a Biotechnology industries |2 fast | |
| 650 | 7 | |a Intellectual property / Valuation |2 fast | |
| 650 | 7 | |a Inventions |2 fast | |
| 650 | 7 | |a Patent laws and legislation |2 fast | |
| 650 | 7 | |a Patent licenses |2 fast | |
| 650 | 7 | |a Patent suits |2 fast | |
| 650 | 7 | |a Pharmaceutical industry |2 fast | |
| 650 | 7 | |a Research and development partnership |2 fast | |
| 651 | 7 | |a United States |2 fast | |
| 700 | 1 | |a Barr, David K. |d 1959- |0 (DE-588)144057417 |4 edt | |
| 700 | 1 | |a Reisner, Daniel L. |0 (DE-588)1188634569 |4 edt | |
| 710 | 2 | |a Kaye Scholer LLP |e Sonstige |0 (DE-588)1085918467 |4 oth | |
| 710 | 2 | |a Practising Law Institute (New York, NY) |e Sonstige |0 (DE-588)1032128-7 |4 oth | |
| 775 | 0 | 8 | |i Revision of |a Arnold & Porter Kaye Scholer LLP. |t Pharmaceutical and biotech patent law |b 2020 Edition |d New York City : Practising Law Institute, [2020] |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-033992222 | ||
Datensatz im Suchindex
| _version_ | 1804184675425452032 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Barr, David K. 1959- Reisner, Daniel L. |
| author2_role | edt edt |
| author2_variant | d k b dk dkb d l r dl dlr |
| author_GND | (DE-588)144057417 (DE-588)1188634569 |
| author_facet | Barr, David K. 1959- Reisner, Daniel L. |
| building | Verbundindex |
| bvnumber | BV048616946 |
| contents | Chapter 1. A brief introduction to the United States Patent System -- Chapter 2. An overview of research & development, product launch, and patent enforcement -- Chapter 3. Utility and patentable subject matter requirements -- Chapter 4. Inventorship -- Chapter 5. Patentability -- Chapter 6. Biological deposits -- Chapter 7. Types of biological and pharmaceutical patents -- Chapter 8. The Hatch-Waxman Act -- Chapter 9. Claim construction -- Chapter 10. Patent infringement -- Chapter 11. Experimental use defense to patent infringement -- Chapter 12. Government funded research: Bayh-Dole and other acts -- Chapter 13. Antitrust, FTC, and state competition law -- Chapter 14. Biologic and biosimilar drug products -- Appendix A. Glossary of biotechnology terminology from case law -- Appendix B. Primer on basic biotechnology concepts -- Appendix C. The science of biosimilars |
| ctrlnum | (DE-599)BVBBV048616946 |
| edition | 2022 edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03354nam a2200601 c 4500</leader><controlfield tag="001">BV048616946</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20230224 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">221219s2022 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781402441394</subfield><subfield code="9">978-1-4024-4139-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1402441398</subfield><subfield code="9">1402441398</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048616946</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical and biotech patent law</subfield><subfield code="c">Arnold & Porter Kaye Scholer LLP ; edited by David K. Barr and Daniel L. Reisner</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2022 edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York City</subfield><subfield code="b">Practising Law Institute</subfield><subfield code="c">[2022]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Band (verschiedene Seitenzählungen)</subfield><subfield code="b">Illustrationen</subfield><subfield code="c">25 cm</subfield><subfield code="e">Beilage: 1 Blatt</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Practicing Law Institute Intellectual property law library</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Auf der Titelseite: "#343424" - Beilage: "Highlights of this edition include"</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Chapter 1. A brief introduction to the United States Patent System -- Chapter 2. An overview of research & development, product launch, and patent enforcement -- Chapter 3. Utility and patentable subject matter requirements -- Chapter 4. Inventorship -- Chapter 5. Patentability -- Chapter 6. Biological deposits -- Chapter 7. Types of biological and pharmaceutical patents -- Chapter 8. The Hatch-Waxman Act -- Chapter 9. Claim construction -- Chapter 10. Patent infringement -- Chapter 11. Experimental use defense to patent infringement -- Chapter 12. Government funded research: Bayh-Dole and other acts -- Chapter 13. Antitrust, FTC, and state competition law -- Chapter 14. Biologic and biosimilar drug products -- Appendix A. Glossary of biotechnology terminology from case law -- Appendix B. Primer on basic biotechnology concepts -- Appendix C. The science of biosimilars</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology / United States / Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology industries / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patent licenses / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research and development partnership / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patent laws and legislation / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Inventions / United States / Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patent suits / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Intellectual property / Valuation / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bioethics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biotechnology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biotechnology industries</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intellectual property / Valuation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inventions</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patent laws and legislation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patent licenses</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patent suits</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Research and development partnership</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barr, David K.</subfield><subfield code="d">1959-</subfield><subfield code="0">(DE-588)144057417</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reisner, Daniel L.</subfield><subfield code="0">(DE-588)1188634569</subfield><subfield code="4">edt</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Kaye Scholer LLP</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1085918467</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Practising Law Institute (New York, NY)</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1032128-7</subfield><subfield code="4">oth</subfield></datafield><datafield tag="775" ind1="0" ind2="8"><subfield code="i">Revision of</subfield><subfield code="a">Arnold & Porter Kaye Scholer LLP.</subfield><subfield code="t">Pharmaceutical and biotech patent law</subfield><subfield code="b">2020 Edition</subfield><subfield code="d">New York City : Practising Law Institute, [2020]</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033992222</subfield></datafield></record></collection> |
| geographic | United States fast |
| geographic_facet | United States |
| id | DE-604.BV048616946 |
| illustrated | Illustrated |
| index_date | 2024-07-03T21:13:04Z |
| indexdate | 2024-07-10T09:43:06Z |
| institution | BVB |
| institution_GND | (DE-588)1085918467 (DE-588)1032128-7 |
| isbn | 9781402441394 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033992222 |
| open_access_boolean | |
| owner | DE-M382 |
| owner_facet | DE-M382 |
| physical | 1 Band (verschiedene Seitenzählungen) Illustrationen 25 cm Beilage: 1 Blatt |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | Practising Law Institute |
| record_format | marc |
| series2 | Practicing Law Institute Intellectual property law library |
| spelling | Pharmaceutical and biotech patent law Arnold & Porter Kaye Scholer LLP ; edited by David K. Barr and Daniel L. Reisner 2022 edition New York City Practising Law Institute [2022] 1 Band (verschiedene Seitenzählungen) Illustrationen 25 cm Beilage: 1 Blatt txt rdacontent n rdamedia nc rdacarrier Practicing Law Institute Intellectual property law library Auf der Titelseite: "#343424" - Beilage: "Highlights of this edition include" Chapter 1. A brief introduction to the United States Patent System -- Chapter 2. An overview of research & development, product launch, and patent enforcement -- Chapter 3. Utility and patentable subject matter requirements -- Chapter 4. Inventorship -- Chapter 5. Patentability -- Chapter 6. Biological deposits -- Chapter 7. Types of biological and pharmaceutical patents -- Chapter 8. The Hatch-Waxman Act -- Chapter 9. Claim construction -- Chapter 10. Patent infringement -- Chapter 11. Experimental use defense to patent infringement -- Chapter 12. Government funded research: Bayh-Dole and other acts -- Chapter 13. Antitrust, FTC, and state competition law -- Chapter 14. Biologic and biosimilar drug products -- Appendix A. Glossary of biotechnology terminology from case law -- Appendix B. Primer on basic biotechnology concepts -- Appendix C. The science of biosimilars Biotechnology / United States / Patents Biotechnology industries / United States Pharmaceutical industry / United States Patent licenses / United States Research and development partnership / United States Patent laws and legislation / United States Inventions / United States / Patents Patent suits / United States Bioethics Intellectual property / Valuation / United States Bioethics fast Biotechnology fast Biotechnology industries fast Intellectual property / Valuation fast Inventions fast Patent laws and legislation fast Patent licenses fast Patent suits fast Pharmaceutical industry fast Research and development partnership fast United States fast Barr, David K. 1959- (DE-588)144057417 edt Reisner, Daniel L. (DE-588)1188634569 edt Kaye Scholer LLP Sonstige (DE-588)1085918467 oth Practising Law Institute (New York, NY) Sonstige (DE-588)1032128-7 oth Revision of Arnold & Porter Kaye Scholer LLP. Pharmaceutical and biotech patent law 2020 Edition New York City : Practising Law Institute, [2020] |
| spellingShingle | Pharmaceutical and biotech patent law Chapter 1. A brief introduction to the United States Patent System -- Chapter 2. An overview of research & development, product launch, and patent enforcement -- Chapter 3. Utility and patentable subject matter requirements -- Chapter 4. Inventorship -- Chapter 5. Patentability -- Chapter 6. Biological deposits -- Chapter 7. Types of biological and pharmaceutical patents -- Chapter 8. The Hatch-Waxman Act -- Chapter 9. Claim construction -- Chapter 10. Patent infringement -- Chapter 11. Experimental use defense to patent infringement -- Chapter 12. Government funded research: Bayh-Dole and other acts -- Chapter 13. Antitrust, FTC, and state competition law -- Chapter 14. Biologic and biosimilar drug products -- Appendix A. Glossary of biotechnology terminology from case law -- Appendix B. Primer on basic biotechnology concepts -- Appendix C. The science of biosimilars Biotechnology / United States / Patents Biotechnology industries / United States Pharmaceutical industry / United States Patent licenses / United States Research and development partnership / United States Patent laws and legislation / United States Inventions / United States / Patents Patent suits / United States Bioethics Intellectual property / Valuation / United States Bioethics fast Biotechnology fast Biotechnology industries fast Intellectual property / Valuation fast Inventions fast Patent laws and legislation fast Patent licenses fast Patent suits fast Pharmaceutical industry fast Research and development partnership fast |
| title | Pharmaceutical and biotech patent law |
| title_auth | Pharmaceutical and biotech patent law |
| title_exact_search | Pharmaceutical and biotech patent law |
| title_exact_search_txtP | Pharmaceutical and biotech patent law |
| title_full | Pharmaceutical and biotech patent law Arnold & Porter Kaye Scholer LLP ; edited by David K. Barr and Daniel L. Reisner |
| title_fullStr | Pharmaceutical and biotech patent law Arnold & Porter Kaye Scholer LLP ; edited by David K. Barr and Daniel L. Reisner |
| title_full_unstemmed | Pharmaceutical and biotech patent law Arnold & Porter Kaye Scholer LLP ; edited by David K. Barr and Daniel L. Reisner |
| title_short | Pharmaceutical and biotech patent law |
| title_sort | pharmaceutical and biotech patent law |
| topic | Biotechnology / United States / Patents Biotechnology industries / United States Pharmaceutical industry / United States Patent licenses / United States Research and development partnership / United States Patent laws and legislation / United States Inventions / United States / Patents Patent suits / United States Bioethics Intellectual property / Valuation / United States Bioethics fast Biotechnology fast Biotechnology industries fast Intellectual property / Valuation fast Inventions fast Patent laws and legislation fast Patent licenses fast Patent suits fast Pharmaceutical industry fast Research and development partnership fast |
| topic_facet | Biotechnology / United States / Patents Biotechnology industries / United States Pharmaceutical industry / United States Patent licenses / United States Research and development partnership / United States Patent laws and legislation / United States Inventions / United States / Patents Patent suits / United States Bioethics Intellectual property / Valuation / United States Biotechnology Biotechnology industries Intellectual property / Valuation Inventions Patent laws and legislation Patent licenses Patent suits Pharmaceutical industry Research and development partnership United States |
| work_keys_str_mv | AT barrdavidk pharmaceuticalandbiotechpatentlaw AT reisnerdaniell pharmaceuticalandbiotechpatentlaw AT kayescholerllp pharmaceuticalandbiotechpatentlaw AT practisinglawinstitutenewyorkny pharmaceuticalandbiotechpatentlaw |